ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Merck Institute for Science Education
Rahway, Estados UnidosPublicaciones en colaboración con investigadores/as de Merck Institute for Science Education (2)
2022
-
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
The Lancet Oncology, Vol. 23, Núm. 5, pp. 659-670
2020
-
Pembrolizumab in microsatellite-instability-high advanced colorectal cancer
New England Journal of Medicine, Vol. 383, Núm. 23, pp. 2207-2218